HYPERSOL 500 MG/G POWDER FOR USE IN DRINKING WATER
HYPERSOL 500 MG/G POWDER FOR USE IN DRINKING WATER
Not authorised
- Oxytetracycline hydrochloride
Product identification
Medicine name:
HYPERSOL 500 MG/G POWDER FOR USE IN DRINKING WATER
HYPERSOL 500 mg/g POLVO PARA ADMINISTRACION EN AGUA DE BEBIDA
Active substance:
- Oxytetracycline hydrochloride
Target species:
-
Chicken
-
Pig
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Oxytetracycline hydrochloride540.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Powder for use in drinking water
Withdrawal period by route of administration:
-
Oral use
-
Chicken
-
Eggsno withdrawal periodEggs: do not use in laying birds producing eggs intended for human consumption
-
Meat and offal7day
-
-
Pig
-
Meat and offal7hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01AA06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Spain
Package description:
- 5 kg bucket: internal bag made of low density polyethylene (in contact with the veterinary medicinal product) in a bucket made of polypropylene – cover made of polypropylene
- 5 kg : Bag made of low density polyethylene (in contact with the veterinary medicinal product) / paper / paper
- 10 kg bags: Bag made of low density polyethylene (in contact with the veterinary medicinal product) / paper / paper
- 1 kg jar: Jar made of high density polyethylene (in contact with the veterinary medicinal product) with a screw cap made of low density polyethylene / aluminium / cardboard operculum / polypropylene
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Huvepharma S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Huvepharma S.A.
Responsible authority:
- (AEMPS)
Authorisation number:
- 2740 ESP
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0251/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 15/03/2023
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 15/03/2023
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 15/03/2023